Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
In February 2022, Sun pharmaceuticals India saw a jump in its cardiac drug formulation Rosuvas, with a market share of over seven percent. This was followed by the pain and analgesics drug, Volini, at seven percent in that time period.
Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Alembic Pharma India revenue 2022, by leading therapy drug
- Premium Statistic Sun Pharma's revenue India 2022, by leading therapy drug
- Premium Statistic Revenue Cadila Healthcare India 2022, by leading therapy drug
- Premium Statistic Growth rate of therapy drugs by Cadila Healthcare India 2022
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Sawai Group's net income FY 2013-2022
- Premium Statistic Market share of therapy drugs by Cadila Healthcare India 2022
- Premium Statistic Sawai Pharmaceutical's total assets FY 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
About the region
10
- Premium Statistic MAT of therapies in Indian pharma 2022
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Growth rate of top therapies in Indian pharmaceuticals 2022
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
Other regions
10
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2023
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2022
- Premium Statistic Volume market share of generic drugs sold by pharmacies in Italy 2001-2022
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Premium Statistic Sawai Group's R&D expenditure FY 2013-2022
- Premium Statistic Value of pharmaceutical sales in Vietnam 2016-2020
- Basic Statistic Generic market value share of community pharmacies in Slovakia 2000-2021
- Premium Statistic Number of employees in the pharmaceutical industry Singapore 2000-2023
- Premium Statistic Leaders in the pharmaceutical drug production in Romania 2021-2022, by revenue
- Premium Statistic Leading pharmaceutical M&A deal value in China 2019, by acquirer
Related statistics
10
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Market share of the Diet Dr Pepper brand in the U.S. 2008-2022
- Keurig Dr Pepper company's market share in the U.S. 2008-2022
- National Beverage company's market share in the U.S. 2009-2022
- Monster Beverage company's market share in the U.S. 2008-2022
- Market share of the Coke Classic brand in the U.S. 2008-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Market share of the Diet Dr Pepper brand in the U.S. 2008-2022
- Keurig Dr Pepper company's market share in the U.S. 2008-2022
- National Beverage company's market share in the U.S. 2009-2022
- Monster Beverage company's market share in the U.S. 2008-2022
- Market share of the Coke Classic brand in the U.S. 2008-2022
Motilal Oswal Group. (March 8, 2022). Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022 [Graph]. In Statista. Retrieved May 19, 2024, from https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/
Motilal Oswal Group. "Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022." Chart. March 8, 2022. Statista. Accessed May 19, 2024. https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/
Motilal Oswal Group. (2022). Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022. Statista. Statista Inc.. Accessed: May 19, 2024. https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/
Motilal Oswal Group. "Market Share of Leading Therapy Drugs from Sun Pharmaceutical Industries Limited across India in February 2022." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/
Motilal Oswal Group, Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022 Statista, https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/ (last visited May 19, 2024)
Market share of leading therapy drugs from Sun Pharmaceutical Industries Limited across India in February 2022 [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096929/india-sun-pharma-therapy-drugs-market-share/